Metraipolis › archive › dc_832c90705bda

Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap — Europe PMC PMID:42746379

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42746379
DOI
10.3389/fonc.2026.1920559
License (as archived)
solo-consultazione
Archived
2026-10-16T07:06:22.477Z
SHA-256 of the archived text
81587756bbb0f10da8d9ad73c8e3093a79aadf7589bc80a2836b506f16658e8d
Stable URL of this page
https://metraipolis.com/documento/dc_832c90705bda

How to cite

Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap — Europe PMC PMID:42746379 — Europe PMC (en), https://europepmc.org/article/MED/42746379 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_832c90705bda (Metraipolis archive dc_832c90705bda, sha256 81587756bbb0f10da8d9ad73c8e3093a79aadf7589bc80a2836b506f16658e8d)
BibTeX
@misc{dc832c90705bda,
  title = {Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap — Europe PMC PMID:42746379},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42746379},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_832c90705bda; sha256 81587756bbb0f10da8d9ad73c8e3093a79aadf7589bc80a2836b506f16658e8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42746379. Agents can read the archived copy with the MCP tool read_document.